# The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)

> **NCT01980940** · PHASE1,PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 70 (actual)

## Conditions studied

- Osteoarthritis Pain

## Interventions

- **DRUG:** Etoricoxib 75 mg 4% DMSO Gel
- **DRUG:** Etoricoxib 75 mg 4% PG Gel
- **DRUG:** Etoricoxib 150 mg 4% DMSO Gel
- **DRUG:** Etoricoxib 150 mg 4% PG Gel
- **DRUG:** Etoricoxib 163 mg 4% DMSO gel
- **DRUG:** Placebo
- **DRUG:** Etoricoxib 50 mg 4% DMSO
- **DRUG:** Matching Placebo to Etoricoxib 50 mg 4% DMSO Gel

## Key facts

- **NCT ID:** NCT01980940
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-23
- **Primary completion:** 2014-11-26
- **Final completion:** 2014-11-26
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980940, "The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01980940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*